Air pollution is a well-known risk factor for respiratory diseases such as asthma and chronic obstructive pulmonary disease ...

Chronic obstructive pulmonary disease (COPD), a condition that affects more than 14 million U.S. adults, is marked by damage ...

Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

All randomized, double-blind, placebo- controlled trials evaluating the efficacy of systemic corticosteroids in COPD exacerbations were identified. Trials that randomized patients to nebulized ...

COPD exacerbations can be life threatening. Learn more about COPD and its different stages. Regular use of spirometry for COPD progression tracking is important for COPD treatment. Each stage ...

Scientists at the Garvan Institute of Medical Research have discovered how a viral infection causes autoimmune disease, disproving a long-standing theory and opening a promising new approach to ...

Chronic hepatitis C infection can lead to autoimmune disease through a "perfect storm" of mutations in B cells, rather than the previously believed mechanism of molecular mimicry.

Researchers have uncovered how chronic hepatitis C infection leads to autoimmune disease, which opens new paths for treatments Scientists at the Garvan Institute of Medical Research have ...

may help improve recovery for patients with chronic obstructive pulmonary disease (COPD) following severe acute exacerbations (AECOPD), paving the way for larger trials to assess its full potential.

A new study published in the Journal of General Internal Medicine, “Incidence and Prevalence of Post‑COVID‑19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER‑Adult Study,” reveals ...